Announcement of the Passing of Emeritus Professor David Penington AC
Penington Institute’s namesake and patron, Emeritus Professor David Penington AC, passed away on 6 January 2023. Professor Penington was one of Australia’s leading public intellectuals and health experts. He courageously advocated for sensible policy in his roles as former chair of the National AIDS Task Force, the Victorian Premier’s Drug Advisory Council, and the Victorian […]
December 2022 | VOL. 19, ED. 6
Colour PDF Greyscale PDF In this issue Pharmacotherapy: “April”, opioid agonist treatment Integrated Care: Tess Mungovan, QuIHN Residential Rehab: Catherine Coles, CAAPS Q&A: “Zoe”, living experience
November 2022 | VOL. 19, ED. 5
Colour PDF Greyscale PDF In this issue Cloud of Confusion: vaping as harm minimisation Prison & Performance Drugs, Disability & the NDIS Q&A Dr Mary Ellen Harrod
October 2022 | VOL. 19, ED. 4
Colour PDF Greyscale PDF In this issue Injecting in NSP-Adjacent Public Facilities CanTEST: Early Findings from Australia’s Flagship Drug-Checking Service Q&A with Professor James Ward Nitrous Oxide | Are ‘nangs’ cause for concern?
September 2022 | VOL. 19, ED. 3
Colour PDF Greyscale PDF In this issue Removing the Barriers to Access Q&A with Kirsten Horsburgh Australia: Hep C-Free by 2030? Interrogating the Gender Gap in Overdose Deaths
Sexual Health and Safety at Festivals Toolkit
Sexual health and safety are essential to our overall health and wellbeing. We all have the right to fulfill and express our sexuality and enjoy good sexual health.
August 2022 | VOL. 19, ED. 2
Colour PDF Greyscale PDF In this issue The waiting game: Australia’s capacity crunch for residential treatment Mick Palmer Q&A The World is Getting Creative for IOAD 2022! Co-occurring mental health and substance use crises: from ‘passing the buck’ to integrated care
July 2022 | VOL. 19, ED. 1
Colour PDF Greyscale PDF In this issue NSP Workers Report Growing Trend of Problematic Steroid Use Stories from the Frontline: Jo Beckett, Youth Projects The state of medicinal cannabis in Australia today Q&A Marguerite White
June 2022 | VOL. 18, ED. 10
Colour PDF Greyscale PDF In this issue Drugs and the 2022 Federal Election Hope on the Horizon: Trials target pharmacotherapy for methamphetamine use New Drug Price Regime Raises Questions Q&A Cheryl Delalande
May 2022 | VOL. 18, ED. 9
Colour PDF Greyscale PDF In this issue Standover tactics: how treatment can be hijacked by coercive control Standing firm: pharmacotherapy use stable as clients age Budget benefit: harm reduction affirmed in federal funding plan Q&A Donna Garcia